As the Brihanmumbai Municipal Corporation (BMC) is conducting the second phase of the serosurvey across three wards, there’s news of citizens volunteering to take part in this crucial survey. BMC’s B.Y.L. Nair Charitable Hospital is one of the multiple institutions approved for human trials of the Covishield vaccine.
Nair Hospital has now mentioned that it has received nearly 500 calls from citizens willing to participate in the trial for the aforementioned vaccine which is researched jointly by the University of Oxford and AstraZeneca, while Serum Institute of India (SII) will market the vaccine in India and other markets under the Covishield brand.
Read - Second Phase Of BMC’s COVID-19 Sero-Survey Will Cover More Than 5,800 Residents
Officials began phase 2 of clinical trials at Pune’s Bharati Vidyapeeth's Medical College and Hospital yesterday with two approved individuals getting the first shot of the vaccine. While the process appears to be fairly simple on the outset, there are a few concerns that the authorities have to deal with before conducting human trials.
The Ethics Committee of Bharati Vidyapeeth's Medical College has reportedly sought information from the Indian Council of Medical Research (ICMR) and SII concerning insurance for the participants as well as the budget for the project.
The BMC conducted its first survey in slums and non-slum areas across R North, F North, and M West wards in July while Phase 2 will also cover the same three wards. This is done so as to get a better idea about the spread of the coronavirus in a particular region.
Also read - ICMR Permits Nair And Kasturba Hospitals To Conduct Plasma Therapy On COVID-19 Patients
Share
Tweet
